Opus Genetics, Inc.
IRD· Nasdaq
IRDOpus Genetics, Inc.
Filed Aug 4, 2017 · 10-Q · 35 days after period end · 0001140361-17-030254
| Metric | Q2 2017 | Q2 2016 | Q2 2015 | Q2 2014 |
|---|---|---|---|---|
| Net Income | $947.06K | -$1.77M | -$3.23M | $194.46K |
| EPS Diluted | $0.03 | -$0.08 | -$0.02 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Opus Genetics, Inc. · CIK 1228627 · Engraved from SEC EDGAR
ended Jun 30, 2017 · filed Aug 4, 2017 · 35 d after period end
